Skip to main content
Premium Trial:

Request an Annual Quote

BioNanomatrix Wins $397K NHGRI Grant to Develop Its Genome Sequencer

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded BioNanomatrix a $397,750 research grant to develop its nanoscale whole genome imaging platform, the company said today.
 
BioNanomatrix is developing a system that allows nanoscale single molecule identification and analysis of the entire genome. The system’s ability to deliver single molecule sensitivity in a highly parallel format with minimal processing will reduce cost and time spent on extensive data and integrative analyses, the company said.
 
The NHGRI awarded the two-year Small Business Investment Research grant under the NIH BioEngineering Nanotechnology Initiative.
 
This is BioNanomatrix’s second NIH grant this year. The company received a National Cancer Institute grant in May to develop a cancer diagnostic prototype.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.